KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

0.491
Delayed Data
As of May 26
 -0.041 / -7.71%
Today’s Change
0.36
Today|||52-Week Range
2.45
-71.62%
Year-to-Date
No recent news for KaloBios Pharmaceuticals Inc.

Today’s Trading

Previous close0.53
Today’s open0.55
Day’s range-- - --
Volume555,204
Average volume (3 months)1,245,508
Market cap$17.6M
Dividend yield--
Data as of 05/26/2015

Growth & Valuation

Earnings growth (last year)+33.53%
Earnings growth (this year)-3.04%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.71

Competitors

 Today’s
change
Today’s
% change
BSPMBiostar Pharmaceutic...-0.01-0.88%
ECTEEcho Therapeutics In...-0.03-1.85%
ABIOARCA Biopharma Inc-0.04-4.55%
RTGNRuthigen Inc+0.06+1.50%
Data as of 05/26/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$38.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive &
Financial Officer
Herbert C. Cross
Chief Scientific Officer
Geoffrey Thomas Yarranton
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers